
FDA Recommends Monovalent XBB.1.5 Vaccine for Fall 2023
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update
As noted in our Key Points this week, Australia has seen a significant uptick in COVID-19 and flu hospitalizations in recent weeks. As we’ve discussed
A California norovirus outbreak of at least 100 cases has been traced back to a single restaurant. A staff member who worked at two fast-food
A new COVID Omicron subvariant (XBB.1.16, known as “Arcturus”) has been making headlines recently for being highly contagious and causing conjunctivitis (pink eye). As discussed
A new Government Accountability Office (GAO) report has noted a critical need to address deficiencies at the Department of Health and Human Services (HHS) that “impaired
With the US declaring an end to the COVID-19 public health emergency (PHE) as of May 11, 2023, CDC has updated its guidance to incorporate
When events occur half a world away, we often see them as having no impact on our own lives or business. But if we consider
With the seasonal weather of the Southern Hemisphere opposite that of the Northern Hemisphere, the rates of seasonal diseases of the Southern Hemisphere can be
On Tuesday, April 18, FDA rescinded authorization for the original monovalent COVID vaccines, instead authorizing the current bivalent vaccines (original and Omicron BA.4/BA.5 strains) to
With rising incidence of tuberculosis (TB) in Europe for the first time in 20 years, as well as in parts of the U.S., COVID is
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.